<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01030198</url>
  </required_header>
  <id_info>
    <org_study_id>C68-08-S</org_study_id>
    <nct_id>NCT01030198</nct_id>
  </id_info>
  <brief_title>Laser Treatment for Fresh Surgical Scars and Mature Scars</brief_title>
  <official_title>Post-Market, Two-Arm, Single Blind, Controlled Study of the RevLite Electro-optic Q-Switched Neodymium-doped Yttrium Aluminum Garnet (EO QS Nd:YAG) Laser System for the Treatment of Scars</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cynosure, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cynosure, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to measure the effectiveness of the RevLite Laser in the
      treatment of both fresh surgical scars and mature/older scars.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Poor enrollment
  </why_stopped>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of improvement in scar appearance, vascularity, height, pliability, pigmentation and any pre-existing pruritis</measure>
    <time_frame>1 month post final treatment (fresh scars) or 3 and 6 months post final treatment (mature scars)</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Fresh Surgical Scars</condition>
  <condition>Mature Scars</condition>
  <arm_group>
    <arm_group_label>Fresh surgical scars</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment of scars</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mature scars</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Treatment of scars</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>RevLite (Laser Treatment)</intervention_name>
    <arm_group_label>Fresh surgical scars</arm_group_label>
    <arm_group_label>Mature scars</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Fitzpatrick Skin Type I-VI and either a fresh surgical scar (with sutures still
             present [or dissolving sutures within 7 days of surgery for facial scars or within 14
             days of surgery for scars on the trunk or extremities) of at least 2cm in length or an
             erythematous and/or hypertrophic scar of at least 2cm in length and of greater than or
             equal to 18 months in duration

          -  Scar is easily divisible into two equal segments for the purpose of the study, or is
             bilateral in nature (e.g., inframammary)

        Exclusion Criteria:

          -  Pregnant, lactating, or is planning to become pregnant

          -  history of cutaneous photosensitization, porphyria, hypersensitivity to porphyrins or
             photodermatosis

          -  any skin pathology/condition that could interfere with evaluation or requires the use
             of interfering topical systemic therapy

          -  coagulation disorder or currently using anti-coagulation medication (including but not
             limited to heavy aspirin therapy)

          -  any condition which, in the investigator's opinion, would make it unsafe for the
             subject to participate in the study

          -  currently enrolled in an investigational drug or device trial, or has received an
             investigational drug or been treated with an investigational device within 30 days

          -  unable to communicate or cooperate with the investigator due to language problems,
             poor mental development, or impaired cerebral function

          -  unreliable for the study, including subjects who engage in excessive alcohol intake or
             drug abuse, or subjects who are unable to return for scheduled follow-up visits

          -  Isotretinoin therapy within 6 months

          -  need to be exposed to artificial tanning devices or excessive sunlight during the
             trial

          -  prior treatment with parenteral gold therapy

          -  does not agree to refrain from other laser treatment, (micro)dermabrasion or topical
             scar treatment creams for the duration of the study

          -  Diabetes Type 1 or 2

          -  Lupus, scleroderma or similar immune system disorder

          -  underlying silicone or other non-absorbable filler in the area of the scar

          -  phenol chemical peel or dermabrasion to the area of the scar within 3 months

          -  Fitzpatrick Skin Type IV, V or VI with a known sensitivity to hydroquinone or is
             unwilling or unable to comply with physician/manufacturer instructions for the use of
             this ingredient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sanctuary Medical Aesthetic Center</name>
      <address>
        <city>Boca Raton</city>
        <state>Florida</state>
        <zip>33431</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 10, 2009</study_first_submitted>
  <study_first_submitted_qc>December 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2009</study_first_posted>
  <last_update_submitted>November 27, 2012</last_update_submitted>
  <last_update_submitted_qc>November 27, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 28, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <pending_results>
    <submitted>April 26, 2013</submitted>
    <returned>June 10, 2013</returned>
    <submitted>March 25, 2014</submitted>
    <returned>April 23, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

